NIH-funded research R01 grant

Exploring how EphB2 and NMDA receptors drive pain after cervical spinal cord injury

Official title: Exploring the EphB2-NMDA receptor interaction in spinal cord injury-induced neuropathic pain

Funded at Thomas Jefferson University · NIH-11371153 · Data updated 2026-11-12

This project looks at a specific molecular interaction in the spinal cord that may contribute to chronic pain after neck-level spinal cord injuries, with the goal of finding new ways to help patients who have neuropathic pain.

More Spinal Cord Injury research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionThomas Jefferson University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 1, 2018
Project endJune 30, 2029
Funding year2026
Award (this year)$603,149
NIH project number5R01NS110385-08
Project IDNIH-11371153 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with cervical spinal cord injury who experience neuropathic pain may benefit from future therapies stemming from this research.

Less likely to help

People without neuropathic pain or those not involved in translational follow-up studies may not directly benefit.

What this research studies

Researchers will study how the EphB2 receptor interacts with NMDA receptors to change nerve signaling in the spinal cord after injury. The work uses animal models to understand how this interaction may make pain signals stronger and longer-lasting. By pinpointing the molecular steps that drive this pain, scientists hope to identify targets for therapies that could reduce neuropathic pain without relying on opioids. The project builds on prior findings that a single amino acid modification on EphB2 influences its interaction with NMDA receptors and pain-related signaling. This renewal aims to further define the mechanism and its role in cervical spinal cord injury–related pain, potentially guiding future translational efforts.

Why it matters

Potential benefit: If successful, the findings could lead to new non-opioid treatments that lessen chronic neuropathic pain after cervical spinal cord injury.

How similar studies have gone: Previous work shows EphB2–NMDA receptor interactions influence pain signaling, supporting potential for meaningful advances with this approach.

Where this research is happening

  • Thomas Jefferson University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Lepore, Angelo C. — Thomas Jefferson University
  • Study coordinator: Lepore, Angelo C.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.